Lewis Michelle Renee sold $159K of PACS

Lewis Michelle Renee (Chief Accounting Officer) sold 3,172 shares of PACS Group, Inc. (PACS) at $50.06 ($0.16M total) on 2026-11-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lewis Michelle Renee
Published Nov 4, 2026, 11:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PACS
Bearish
medium confidence
Mentioned
$PACS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSBearishLow
01

Why it matters

The insider sale is modest but may trigger short‑term selling pressure.

02

Market read

A small insider sale by a senior officer, likely to cause limited short‑term price impact.

03

What to watch

The officer's 10b5-1 plan may have been pre‑scheduled, reducing informational value.

Relevance 3/10Novelty 3/10Timing: after-hours today

Background

Form 4 filings disclose insider transactions and are primary sources for such events.

Company-level read

Ticker impact

$PACSBearishMedium confidence
Context

Chief Accounting Officer sold 3,172 shares for $158,775.73 via a 10b5-1 plan on 2026-11-04.

Expected impact

likely slight downward pressure as the market prices the insider sell.

Evidence & confidence

The sale is modest but involves a senior officer; such transactions often lead to short-term sell pressure.

Market effects

Minimal impact on the broader healthcare services sector.

Limited to US investors tracking PACS.

No significant global effect.

Counterpoint

The sale could be routine liquidity need, not a lack of confidence.

Key entities

  • Lewis Michelle Renee

    Chief Accounting Officer of PACS Group, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PACSMedAI 8/10

What PACS Group (PACS) Said on Its Q3 Earnings Call

PACS Group reported 196 mature, 90 ramping, and 35 new skilled nursing facilities with occupancy ranging from 76.2% to 93.1%. The company acquired 32 Florida and 10 Texas skilled nursing operations post-quarter. PACS raised its 2026 revenue outlook to $5.95B-$6.05B and adjusted EBITDA to $685M-$695M, citing strength in existing operations and new acquisitions. Operating cash flow was $583.1M for the first nine months of 2026, with $707.4M in available liquidity.

$PACSHighAI 8/10

PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops

PACS Group Inc (NYSE:PACS) reported Q3 2026 revenue growth of 6.4%, with adjusted EBITDA up 33.6% to $175.7M. The company raised full-year guidance, citing strong occupancy and skilled mix improvements. PACS also highlighted a robust acquisition pipeline and integration plans for 31 Eduro facilities. Challenges include lower metrics at newly acquired facilities and ongoing government investigations.

$PACSHigh

Why is PACS stock surging today?

PACS Group Inc (PACS) stock rose 6.0% in after-hours trading after beating Q3 2026 earnings and revenue estimates. The company also raised its full-year 2026 Adjusted EBITDA and revenue guidance. Analysts maintain a 'Moderate Buy' rating with an average price target of $58.80. The surge was driven by company-specific news.